...
首页> 外文期刊>Medicinal chemistry >A QSAR study on the cytotoxicity of podophyllotoxin analogues against various cancer cell lines.
【24h】

A QSAR study on the cytotoxicity of podophyllotoxin analogues against various cancer cell lines.

机译:QSAR研究鬼臼毒素类似物对各种癌细胞系的细胞毒性。

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

The powerful inhibitory activity of podophyllotoxin (a natural product) on cell growth led to the development of clinically useful anticancer agents such as etoposide, teniposide, and etopophos. Although, these podophyllotoxin derivatives show good clinical effects against various cancers, its use often results in various undesired side effects, drug resistance, and cytotoxicity towards the normal cells. In order to overcome these limitations, it is essential to search new podophyllotoxin analogues with improved anticancer activity and fewer side effects to gain the maximum benefits for the cancer patients. With this purpose, the cytotoxicity data of two series of podophyllotoxin derivatives against four different cancer cell lines was used to develop 4 QSAR models. Hydrophobic property of the molecules was found one of the most important determining factors for their activity. The developed QSAR models showed a good correlative and predictive abilities having r(2) = 0.960 to 0.836 and q(2) = 0.911 to 0.705. On the basis of QSAR 1, two compounds (10-10 and 10-11) are suggested as potential synthetic targets. Statistical diagnostics and internal validation (cross validation and Y-randomization) tests have validated all the QSAR models. These QSAR models could be useful in the rational design of potential drug molecules with an enhanced inhibitory potency.
机译:鬼臼毒素(一种天然产物)对细胞生长的强大抑制作用导致了临床上有用的抗癌药的开发,如依托泊苷,替尼泊苷和依托泊磷。尽管这些鬼臼毒素衍生物显示出对各种癌症的良好临床效果,但其使用通常会导致各种不良副作用,耐药性以及对正常细胞的细胞毒性。为了克服这些限制,必须寻找具有改善的抗癌活性和较少副作用的新鬼臼毒素类似物,以使癌症患者获得最大利益。为了这个目的,使用两个系列鬼臼毒素衍生物对四种不同癌细胞系的细胞毒性数据来开发4个QSAR模型。发现分子的疏水性质是其活性的最重要的决定因素之一。已开发的QSAR模型显示出良好的相关性和预测能力,其中r(2)= 0.960至0.836,q(2)= 0.911至0.705。根据QSAR 1,建议使用两种化合物(10-10和10-11)作为潜在的合成目标。统计诊断和内部验证(交叉验证和Y随机化)测试已经验证了所有QSAR模型。这些QSAR模型可用于合理设计具有增强抑制效力的潜在药物分子。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号